Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
May 2 — Mental health advocates hope that a provision included in recent Medicaid managed care regulations will jump-start discussions in Congress about fixing a decades-old policy that limits Medicaid reimbursement for certain inpatient mental health care.
Deep within its final rule for Medicaid managed care plans, the CMS said it would allow Medicaid reimbursement for so-called institutions of mental disease (IMD). According to the rule, if certain conditions are met—such as a stay lasting no longer than 15 days—the facility can treat patients for psychiatric or substance abuse disorder and the state Medicaid program will reimburse it.
Federal Medicaid law excludes payments for adult beneficiaries ages 21-64 who are residents of an IMD, so allowing managed care plans to cover those services could be a potential game changer, stakeholders said. An IMD is defined in the law as a hospital nursing facility or other institution greater than 16 beds that is engaged in providing diagnosis, treatment or care of people with mental diseases. The exclusion for paying for a stay in an IMD, which dates to Medicaid’s enactment, has been called outdated and generally harmful.
The long-awaited final rule would completely overhaul the Medicaid managed care industry. The final rule was released April 25 and aims to align Medicaid and Children's Health Insurance Program (CHIP) managed care plans with other sources of health insurance coverage (80 HCDR, 4/26/16).
Lawmakers in both the House and Senate are working on legislation to overhaul the country's mental health treatment system, and advocates have been pressing them to include a repeal of the IMD exclusion.
“This is a really important development. It's the first time the federal government has put in a regulation an interpretation of the IMD exclusion that allows for payments to psychiatric hospitals,” Mark Covall, president and CEO of the National Association of Psychiatric Health Systems (NAPHS), told Bloomberg BNA. “The rule shows the administration knows we have a crisis on our hands with respect to inpatient psych care. So now it’s really about crafting something, a targeted exception, so we can give people in Medicaid access to psychiatric care.”
According to Covall, the ban on IMD coverage was limiting access to care, so Medicaid beneficiaries weren't getting the same level of treatment as people in the commercial sector. The final rule will allow the almost two-thirds of the 72 million Medicaid beneficiaries enrolled in managed care plans access to the care they need, Covall said. According to the CMS, about 7 percent of adults in the 21-64 age category meet the criteria for serious mental illness requiring at least some inpatient treatment, and 13.8 percent experience serious substance abuse disorders.
“The rule affects more than half of Medicaid beneficiaries,” Covall said. “This rule provides an opportunity for Congress to finish the job.”
A former Senate Republican staffer told Bloomberg BNA May 2 that the final rule creates a structural disadvantage between fee-for-service Medicaid and managed care, which could make an argument for lawmakers to take up the IMD exclusion issue. However, the window for action is closing fast, he said.
Senators are still negotiating the future of a broad bipartisan mental health reform bill. The Mental Health Reform Act (S. 2680) was approved in March by the Senate Health, Education, Labor and Pensions Committee, but more work needs to be done before the Senate can have a vote. A repeal of the IMD exclusion wasn't included, but senators will seek to include such an amendment once the bill gets taken up on the floor.
A House mental health reform bill (H.R. 2646) does include an IMD repeal provision, but the Congressional Budget Office said the change would cost between $40 billion and $80 billion over 10 years. The bill's sponsor, Rep. Tim Murphy Murphy (R-Pa.), and mental health advocates say that number isn't realistic and are working with the CBO to bring the cost down.
According to the former staffer, the CMS could argue that its change was cost neutral. There are a significant number of additional providers available for managed care plans to utilize, but they won't be paid any differently than they would have under their already capitated payment. There will be a cost for Congress to change the policy for fee-for-service, and they need to find a pay-for, he said.
The House bill is awaiting a markup in the Energy and Commerce Committee.
The committee's chairman, Rep. Fred Upton (R-Mich.), praised the CMS final rule.
“This commonsense change will have an important impact on families focused on getting their loved ones the care they need, and that’s good news,” Upton said. “We still have work to do to bring this Great Society program into the 21st century, but this modernization of policy represents a real win when it comes to providing care for the mentally ill.”
Daniel Raymond, policy director for the Harm Reduction Coalition, told Bloomberg BNA the price tag of repeal has given lawmakers some pause. However, because the rule makes short-term stays in inpatient psychiatric hospitals available for the managed care population, it could “force the issue” with Congress.
Covall agreed that finding a pay-for would be difficult, but because half the Medicaid population is already covered under the rule, it would be significantly less than any previous estimates—especially if the law limits the inpatient stays to 15 days, like the final rule.
Passing a mental health reform bill that doesn't address the IMD exclusion will be challenging, the former staffer said. Congress will also be pressured to act by over-burdened psychiatric hospitals. Allowing Medicaid coverage of inpatient psychiatric services would take pressure off them. In addition, the handful of weeks left in the congressional session are all about the lawmakers who want to put points on the board during the re-election season, and mental health would look good, he said.
To contact the reporter on this story: Nathaniel Weixel in Washington at email@example.com
To contact the editor responsible for this story: Brian Broderick at firstname.lastname@example.org
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)